Brief: Firebrick Pharma Executes License And Distribution Agreement For Nasodine Nasal Spray
12/02/2025 01:31
Feb 12 (Reuters) - Firebrick Pharma Ltd FRE.AX :
* FIREBRICK PHARMA - LICENSE AND DISTRIBUTION AGREEMENT
WITH
MAKANS LIMITED FOR NASODINE NASAL SPRAY
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement